Faeth Therapeutics (FTH) Operating Leases (2022 - 2025)
Faeth Therapeutics' (FTH) quarterly Operating Leases came in at $59000.0 in Q4 2025, down 95.87% YoY from $1.4 million in Q4 2024, and down 59.59% on a QoQ basis from $146000.0 in Q3 2025.
Faeth Therapeutics (FTH) Operating Leases (2022 - 2025) Analysis & Trends
Faeth Therapeutics (FTH) has 4 years of Operating Leases data on file, last reported at $59000.0 in Q4 2025.
- Quarterly Operating Leases fell 95.87% year-over-year to $59000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59000.0 (down 95.87% YoY) and the FY2025 annual result came in at $59000.0, down 95.87% from the prior year.
- Operating Leases eased to $59000.0 in Q4 2025, from $146000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $5.3 million in Q1 2022 to a low of $59000.0 in Q4 2025.
- A 4-year average of $2.7 million and a median of $2.8 million in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases declined 21.96% — and 2025, when it sank 95.87%.
- Tracing FTH's Operating Leases over 4 years: stood at $4.3 million in 2022, then slumped by 30.58% to $3.0 million in 2023, then slumped by 52.38% to $1.4 million in 2024, then slumped by 95.87% to $59000.0 in 2025.
- The last three Operating Leases figures came in at $59000.0 (Q4 2025), $146000.0 (Q3 2025), and $592000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | 146,000.00 |
| Jun 30, 2025 | 592,000.00 |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | 4.12 Mn |
| Dec 31, 2022 | 4.32 Mn |
| Sep 30, 2022 | 4.64 Mn |
| Jun 30, 2022 | 4.97 Mn |
| Mar 31, 2022 | 5.28 Mn |